![Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) | npj Digital Medicine Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) | npj Digital Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41746-020-0260-4/MediaObjects/41746_2020_260_Fig1_HTML.png)
Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) | npj Digital Medicine
![Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem | Nature Reviews Drug Discovery Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd.2017.153/MediaObjects/41573_2017_Article_BFnrd2017153_Fig1_HTML.jpg)
Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem | Nature Reviews Drug Discovery
![The importance of biometric functions to improving data quality in Clinical Trials | World Pharma Today The importance of biometric functions to improving data quality in Clinical Trials | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/2018/11/images_article_Articles_Nov_2018_Quanticate_biosimilar_development.jpg)
The importance of biometric functions to improving data quality in Clinical Trials | World Pharma Today
![Vivalink Biometrics Data Platform Help Monitor Oncology Patients in Clinical Trials and Patient Care|Medigy Vivalink Biometrics Data Platform Help Monitor Oncology Patients in Clinical Trials and Patient Care|Medigy](https://www.medigy.com/news/9eeedd30-7af6-57e3-a7e1-e8386fc723a9-featuredImage.jpeg)